The most recent trading session ended with Pfizer (PFE) standing at $25.60, reflecting a -0.43% shift from the previouse trading day's closing. This change was narrower than the S&P 500's daily loss ...

We recently published a list of the 11 Best Pharma Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against the other best ...

Pfizer’s shares (currently trading at $26.70) have posted a disappointing 10.2% loss, well below the S&P 500’s 3.8% gain.

Pfizer (PFE) is one of the stocks most watched by ... between trends in earnings estimate revisions and short-term stock price movements. Pfizer is expected to post earnings of $0.67 per share ...

Shares of Pfizer Inc. PFE slid 2.44% to $25.99 Tuesday, on what proved to be an all-around poor trading session for the stock ...

Shrewd investors know that bear markets open up great opportunities to pick up shares of excellent companies from the ...

Pfizer, under the leadership of Albert Bourla, remains under pressure from critics, pessimists, and others, which is not surprising since its stock price is ... shares of AZN, PFE either through ...

I confirm my "Buy" rating because I believe PFE has got a bigger upside than last year, although its stock price basically stayed flat. Analyst’s Disclosure: I/we have a beneficial long position ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...